A company's offering statement — it's kicking off a Regulation Crowdfunding raise.

AlphaRose Therapeutics Inc

AlphaRose Therapeutics Inc filed a Form C — new offering — with the SEC on Jan 29, 2025. The Regulation Crowdfunding offering seeks $123,999, up to a maximum of $1,234,998 on StartEngine. Investors receive: Common Stock at $1.35. The offering closes 04-30-2025.

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.